The life cycle
management company

Learn more

Committed to realising the full potential of established medicines

We use patient and clinician insights to identify areas of ongoing unmet need, then use our expertise as a leader in life cycle management to find innovative ways to deliver better outcomes for patients.

More about us

Our numbers

  • 15+


  • 25+


  • 160+


  • 280+


Our portfolio

Heart icon


Our key products include Inderal®, Tenormin®, Tenoretic®, Zestril®and Zestoretic®

Endocrinology icon


Our key products include Bonviva®, Rocaltrol® and Synacthen®

Brain icon


Our key products include Anaprox®, Naprosyn®, Toradol® and Valium®

Stomach icon


Our key products include Bondronat®, Dipentum® and Kytril®

A collaborative and experienced partner

We partner with innovative pharma, digital health ‘pioneers’, tech platforms, distributors and suppliers who share our goal to sustainably improve the patient experience and communities they are part of.

Partnering with us

A team of inquisitive minds

Pharmanovia’s success is down to its people. Our inclusive, high-performance culture provides opportunities to continually learn, develop and make change happen.

Careers at Pharmanovia

Latest news

16th May 2024

Closed Loop Medicine and Pharmanovia commence study for their first precision medicine combination therapeutic

PRESS RELEASE: For global business and medical media only 16 May 2024 Closed Loop Medicine and...

More information
6th February 2024

Pharmanovia appoints new regional manager – Spain, Portugal and France

For business and pharma trade media only BASILDON, UK, 30 January 2024 Pharmanovia, a global pharmaceutical...

More information
10th November 2023

Pharmanovia CEO, James Burt appointed Chair of Medicines for Europe’s Value Added Medicines (VAM) sector group

PRESS RELEASE (business and pharma trade only) FOR IMMEDIATE RELEASE, Basildon, 9 November 2023 Pharmanovia, a...

More information

Our memberships

We are proud to be a member of EMIG, the Ethical Medicines Industry Group, and Medicines for Europe.